RARA and acute promyelocytic leukemia: PML nuclear bodies (NB) are disrupted in PML-RARA-driven APL [89], which may disturb the PML-sumoylation-H3K9me3 axis and consequently perturb H3K9me3 at KAP1 TE target families.